Literature DB >> 10924560

Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients.

L Grazioli1, M P Federle, T Ichikawa, E Balzano, M Nalesnik, J Madariaga.   

Abstract

PURPOSE: To report and correlate the clinical, histopathologic, and imaging findings in 15 patients with liver adenomatosis.
MATERIALS AND METHODS: Fifteen adult patients had more than 10 hepatic adenomas each and no history of glycogen storage disease or anabolic steroid use. Ten of them underwent bolus-enhanced dynamic computed tomography (CT) with or without magnetic resonance (MR) imaging, ultrasonography, and/or angiography.
RESULTS: Clinical abnormalities included abdominal pain in 11 (73%) and hepatomegaly in 10 (67%) patients, and abnormal liver function in 10 (91%) of 11 patients. The number of adenomas in each patient was 10-50 at imaging, but many more lesions were found in the resected specimens. Hemorrhage was commonly found within adenomas at histopathologic analysis, but only four patients had clinical and imaging evidence of substantial hemorrhage. In all patients, the adenomas increased over time, and two patients developed hepatocellular carcinoma. CT and MR features of the adenomas included evidence of hypervascularity (63%), intratumoral fat (50% of patients at CT, 80% at MR), and decreased conspicuity at portal venous and delayed-phase imaging. Fifty percent of patients had congenital or acquired hepatic vascular abnormalities.
CONCLUSION: The imaging and histopathologic features of individual adenomatous lesions are similar to those reported in young women who are taking oral contraceptives. However, the lesions in liver adenomatosis are not steroid dependent but rather multiple, progressive, and symptomatic, and they are more likely to lead to impaired liver function, hemorrhage, and perhaps malignant degeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924560     DOI: 10.1148/radiology.216.2.r00jl38395

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  35 in total

Review 1.  [Ultrasound contrast agents for liver diagnostics].

Authors:  A-J Lemke; S S Chopra; S M Niehues; R Felix
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 2.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

3.  Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization.

Authors:  Sawako Kobayashi; Hiroki Sakaguchi; Masaki Takatsuka; Takehisa Suekane; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada
Journal:  Hepatol Int       Date:  2009-03-05       Impact factor: 6.047

4.  Current imaging strategies of primary and secondary neoplasms of the liver.

Authors:  Linda Fielding
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

5.  Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.

Authors:  N Shao; A Pandey; M A Ghasabeh; P Khoshpouri; P Pandey; F N Varzaneh; M Zarghampour; D Fouladi; T M Pawlik; R A Anders; I R Kamel
Journal:  Clin Radiol       Date:  2018-07-18       Impact factor: 2.350

6.  Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Satoshi Sekiguchi; Kazuyuki Ishida; Takehiko Igarashi; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 7.  [Diagnosis and differential diagnosis of benign liver tumors and tumor-like lesions].

Authors:  M Galanski; S Jördens; J Weidemann
Journal:  Chirurg       Date:  2008-08       Impact factor: 0.955

Review 8.  [Surgical therapy of benign liver tumors].

Authors:  M Loss; C Zülke; A Obed; O Stöltzing; H J Schlitt
Journal:  Chirurg       Date:  2008-08       Impact factor: 0.955

9.  A missense TCF1 mutation in a patient with mody-3 and liver adenomatosis.

Authors:  Antonio Marcondes Lerario; Luciana Pinto Brito; Beatriz Marinho Mariani; Maria Candida B V Fragoso; Marcel Autran Cesar Machado; Roberto Teixeira
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.